Archives

img-01

China’s Hospital Market

The hospital industry in China is growing at an extraordinary rate. Thirty percent of the country's 2009 healthcare reform initiatives are earmarked for building new health facilities. In other words, since 2009, the Chinese government has been injecting $37 billion into the... Read More

img-01

Japan Slides Off the Patent Cliff

Japan’s looming ‘patent cliff’ has analysts wondering what Japanese pharmaceutical companies will do in an attempt to offset revenue losses when their blockbuster patents expire over the next few years. The ‘patent cliff’ phenomenon that began in 2009 is expected to peak... Read More

img-01

Malaysia Plans Growth for Healthcare Sector

With some of the highest levels of national healthcare spending in Asia (ranking third after Vietnam and South Korea), Malaysia is taking hold of its strategic strengths in the pharmaceuticals and medtech sectors, among others, to expand the country’s economic growth. The... Read More

img-01

Updates on China’s Medical Device Market

China's economic growth has skyrocketed during the last 15 years. In the second quarter of 2010, China's nominal gross domestic product (GDP) of $1.33 trillion surpassed that of Japan, $1.29 trillion. Along with the economic surge, China's healthcare market also is growing.... Read More

img-01

Reimbursement in China

The global recession has left medical companies scrambling to find new markets. China's GDP, adjusted for purchasing power parity, is currently second in the world and has surpassed Japan's. Medical companies should focus on this growing market. However, before entering the Chinese... Read More

img-01

Diabetes Explosion in Asia

Asia's cases of diabetes are at an all-time high. The International Diabetes Federation (IDF) estimates that more than 125 million people in Asia are suffering from the condition this year. These numbers are climbing quickly. There likely will be more than 200... Read More